Hiv 1 Reverse Transcriptase | List of Frontiers open access articles

Original Research

Published on 14 Feb 2022

Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase

in Structural Biology

Kathleen M. Frey
Nicole Bertoletti
Albert H. Chan
Joseph A. Ippolito
Mariela Bollini
Krasimir A. Spasov
William L. Jorgensen
Karen S. Anderson

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2022.805187

6,292 views
10 citations

Original Research

Published on 05 Nov 2025

HIV nucleocapsid proteins as targets for novel 1,2-benzisothiazol-3(2H)-one benzenesulfonamides: synthesis and antiretroviral activity

in Virology

Roberta Loddo
Matteo Incerti
Elda Favari
Valeria Manca
Marta Cogoni
Rebecca Piras
Luca Virdis
Vanessa Palmas
Elena Tamburini
Paolo La Colla

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1664231

1,356 views

Original Research

Published on 14 Jul 2022

APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants

in Modeling of Viral Replication and Pathogenesis

Richa Dwivedi
Youya Wang
Christopher Kline
Douglas K. Fischer
Zandrea Ambrose

Frontiers in Virology

doi 10.3389/fviro.2022.919825

3,004 views
3 citations

Original Research

Published on 04 Feb 2022

Sampling of Protein Conformational Space Using Hybrid Simulations: A Critical Assessment of Recent Methods

in Biological Modeling and Simulation

Burak T. Kaynak
James M. Krieger
Balint Dudas
Zakaria L. Dahmani
Mauricio G. S. Costa
Erika Balog
Ana Ligia Scott
Pemra Doruker
David Perahia
Ivet Bahar

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2022.832847

9,648 views
28 citations

Original Research

Published on 10 Dec 2025

Optimisation of peptides targeting reverse transcriptase HIV-1 using QSAR, machine learning, and computational approaches

in Experimental Pharmacology and Drug Discovery

Fachrur Rizal Mahendra
Indira Prakoso
Alfa Marzelino
Muhamad Rizqy Fadhillah
Syukriyansyah
Muhammad Marsha Azzami Hasibuan
Juniza Firdha Suparningtyas
Mikael Kristiadi
Aprijal Ghiyas Setiawan
Faris Izzatur Rahman

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1707377

2,220 views
1 citation

Review

Published on 26 Aug 2014

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

in Virology

Yuqing Feng
Tayyba T. Baig
Robin P. Love
Linda Chelico

Frontiers in Microbiology

doi 10.3389/fmicb.2014.00450

20,386 views
107 citations

Articles

Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase

HIV nucleocapsid proteins as targets for novel 1,2-benzisothiazol-3(2H)-one benzenesulfonamides: synthesis and antiretroviral activity

APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants

Sampling of Protein Conformational Space Using Hybrid Simulations: A Critical Assessment of Recent Methods

Optimisation of peptides targeting reverse transcriptase HIV-1 using QSAR, machine learning, and computational approaches

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif